Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2021-09-22 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
祥生医疗2021年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2021 first extraordinary general meeting of shareholders of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the meeting date, attendance, voting results, and legal compliance, including lawyer witness statements. It does not contain financial statements or detailed financial analysis but focuses on the meeting proceedings and voting outcomes. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1405 characters), but it is not merely announcing the availability of a report; it provides the actual voting results and meeting details. Therefore, the correct classification is DVA with high confidence.
2021-09-22 Chinese
无锡祥生医疗科技股份有限公司2021年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as "2021年第一次临时股东大会会议资料" which translates to "2021 First Extraordinary General Meeting (EGM) Meeting Materials". It contains detailed meeting instructions, agenda, voting procedures, and proposed resolutions such as changing the company address and amending the articles of association. The content is focused on the materials and procedures for a shareholders' meeting rather than the announcement of voting results or a proxy solicitation. It is not a brief announcement but a comprehensive set of meeting materials. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during general meetings. Although it is an extraordinary meeting, the category AGM-R applies to all general meeting materials. The document length is over 5,000 characters and contains substantive content, so it is not a report publication announcement or regulatory filing. Therefore, the classification is AGM-R with high confidence.
2021-09-13 Chinese
祥生医疗关于变更公司注册地址、修订公司章程并办理工商变更登记的公告
Board/Management Information Classification · 95% confidence The document is a company announcement regarding the change of the company's registered address and the amendment of the company bylaws (章程). It mentions that the board of directors has approved the proposal and that it requires approval at the upcoming extraordinary general meeting. The document does not contain financial statements, audit information, or detailed financial data. It is a formal announcement about corporate governance changes and administrative updates, specifically about the registered address and bylaws amendment. This fits best under the category of Board/Management Information (MANG), which includes announcements of changes in company governance or management-related matters. The document is short (888 characters) and is not a report or a notice of voting results, nor is it a proxy solicitation or a regulatory filing. Therefore, the classification is MANG with high confidence.
2021-09-03 Chinese
祥生医疗关于召开2021年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2021 first extraordinary general meeting of shareholders for Wuxi Xiangsheng Medical Technology Co., Ltd. It details the meeting date, voting methods, agenda items, registration procedures, and includes an authorization proxy form for voting. There is no financial data, earnings, or report content. The document is an announcement related to a shareholders' meeting, specifically a notice to convene the meeting and provide voting information. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and voting procedures rather than solicitation materials or voting results, it is best classified as a Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters and it is not a report publication announcement or certification. Therefore, the classification is PSI with high confidence.
2021-09-03 Chinese
无锡祥生医疗科技股份有限公司章程修正案
Governance Information Classification · 95% confidence The document is titled '章程修正案' which translates to 'Articles of Association Amendment'. It details specific amendments to the company's articles of association, including changes to the company address and postal code. The document references relevant laws and regulations governing company articles but does not contain financial data, management changes, or voting results. It is a governance-related document focused on internal company rules and structure. Therefore, it fits the category of Governance Information (CGR). The document length is short and it is not an announcement of a report but the actual amendment text.
2021-09-03 Chinese
国金证券股份有限公司关于无锡祥生医疗科技股份有限公司2021 年半年度持续督导跟踪报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2021 年半年度持续督导跟踪报告" which translates to "2021 Semi-Annual Continuous Supervision Follow-up Report". It is issued by Guojin Securities Co., Ltd. as the sponsor institution responsible for continuous supervision of Wuxi Xiangsheng Medical Technology Co., Ltd. The document references regulatory frameworks related to securities issuance and listing, continuous supervision work, and includes detailed financial data for the first half of 2021, risk factors, compliance with fundraising usage, and other operational and governance information. The document is about a half-year period (January to June 2021) and contains substantive financial data and analysis, not just an announcement or summary. It is not a full annual report (10-K), but a mid-year report with detailed financial and operational information. This fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-08-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.